HDAC-IN-52 structure
|
Common Name | HDAC-IN-52 | ||
---|---|---|---|---|
CAS Number | 2075787-77-6 | Molecular Weight | 396.44 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C24H20N4O2 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of HDAC-IN-52HDAC-IN-52 is a pyridine-containing HDAC inhibitor, with IC50s of 0.189, 0.227, 0.440 and 0.446 μM for HDAC1, HDAC2, HDAC3, and HDAC10, respectively. HDAC-IN-52 can be used for the research of cancer[1]. |
Name | HDAC-IN-52 |
---|
Description | HDAC-IN-52 is a pyridine-containing HDAC inhibitor, with IC50s of 0.189, 0.227, 0.440 and 0.446 μM for HDAC1, HDAC2, HDAC3, and HDAC10, respectively. HDAC-IN-52 can be used for the research of cancer[1]. |
---|---|
Related Catalog | |
Target |
hHDAC1:0.189 μM (IC50) hHDAC2:0.227 μM (IC50) hHDAC3:0.440 μM (IC50) hHDAC10:0.446 μM (IC50) |
In Vitro | HDAC-IN-52 (compound 8f) (72 hours) 抑制 HCT116,A549 和 K562 细胞的增殖,IC50 值分别为 0.43,1.28 和 0.37 μM[1 ]。 HDAC-IN-52 (1-5 μM; 24-48 h) 在 48 小时后显着诱导白血病 U937 细胞死亡,G1 前期阻滞分别为 76% 和 100%[1]。 HDAC-IN-52 (1-5 μM; 48 h) 增加 p21,BAX 和 BAK 的 mRNA 表达,下调细胞周期蛋白 D1 和 BCL-2[1]。 |
References |
Molecular Formula | C24H20N4O2 |
---|---|
Molecular Weight | 396.44 |
Storage condition | -20°C |